Advertisement

Topics

Novartis could avoid trial with $1B settlement

05:56 EDT 17 May 2019 | Pharmaceutical Manfacturing

Just days before a trial targeting an alleged kickback scheme launched by Novartis is set to begin, there are hints that the company could reach a massive settlement with the U.S. government.

Original Article: Novartis could avoid trial with $1B settlement

NEXT ARTICLE

More From BioPortfolio on "Novartis could avoid trial with $1B settlement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...